| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
SPECIAL SECTION |
Department of Medicine (Oncology), University of North Carolina, Chapel Hill, North Carolina, USA and Community and Family Medicine, Duke University, Durham, North Carolina, USA
Correspondence: Barrie R. Cassileth, Ph.D., 8033 Old NC 86, Chapel Hill, NC 27516, USA. Telephone and Fax: 919-967-2184; e-mail: brc{at}med.unc.edu -or- barrie{at}nando.net
Alternative and complementary therapies differ importantly, and the distinction between the two is crucial for clinical oncologists. "Alternative" or unproven therapies are treatments used independent of surgery, radiation and chemotherapy. They can be dangerous directly and also by delaying patients receipt of mainstream care. In contrast, complementary therapies typically are adjuncts to mainstream medicine. They can provide symptom control and noninvasive palliation with minimal side effects, improve patients well-being and enhance cancer medicine. Complementary therapies represent a desired addition and balance to technologically sophisticated cancer care.
This article has been cited by other articles:
![]() |
H. Upur, A. Yusup, I. Baudrimont, A. Umar, B. Berke, D. Yimit, J. C. Lapham, E. E. Creppy, and N. Moore Inhibition of cell growth and cellular protein, DNA and RNA synthesis in human hepatoma (HepG2) cells by ethanol extract of abnormal Savda Munziq of traditional Uighur medicine Evid. Based Complement. Altern. Med., October 15, 2008; (2008) nen062v1. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| THE ONCOLOGIST | STEM CELLS | CME | ALPHAMED PRESS JOURNALS |